The murine Mls-i antigen is the prototype of endogenous superantigens, molecules whose activities lead to deletion of T cells expressing certain T-cell receptor V(J genes from the mature repertoire. However, Mis-i also stimulates T cells expressing these particular VP3 genes (V,6, V(37, V38.1, and V139) in vitro, making it one of the strongest known T-cell activators. We have recently reported that the MIs-I gene is closely linked to the endogenous mammary tumor virus Mtv-7. We now demonstrate that Mls-1 is encoded by the open reading frame in the U3 region of the long terminal repeat of Mtv-7.
The endogenous superantigens comprise a family of molecules that are recognized by the T-cell receptor (TCR) Vf3 segment only, regardless of the third hypervariable region and a-chain expression. Since these antigens lead to deletion of T cells expressing particular V,8 genes, they have a profound effect on the mature T-cell repertoire (1) (2) (3) . The mapping of a VfI5 tolerizing element close to the endogenous mammary tumor virus (MMTV) provided the first hint of the molecular nature of this molecule (4) . This observation prompted us to map the various Mls antigens in inbred mice, and we were able to identify Mls-1 with Mtv-7 and to associate the genes encoding the MlsC phenotype with Mtv-6, Mtv-13, and Mtv-J (5) . Other superantigens have also been associated with the presence of various endogenous and infectious mammary tumor viruses (6) (7) (8) . Recently it has been shown that the open reading frame (ORF) in the U3 region of the MMTV long terminal repeat (LTR) of two infectious MMTVs and of the proviruses Mtv-1, Mtv-3, Mtv-8, and Mtv-9 encodes superantigens (9) (10) (11) (12) .
We have extended these observations to show that the ORF of Mtv-7 encodes Mls-1. However, from the results we obtained in transfection experiments we surmise that the control of expression of this activity is complex. We have determined the nucleotide sequence of the Mtv-7 ORF and compared its predicted amino acid sequence to that of other MMTV ORFs. Two polymorphic regions were identified where the Mtv-7-derived sequence differs drastically from the others. It is likely that these segments contribute to TCR V,8 specificity and/or constitute superantigen/major histocompatibility complex class II contact sites. § MATERIALS AND METHODS Cloning of Mtv-7. Genomic DNA derived from the recombinant inbred mouse strain AKXD-15 was digested with EcoRI. A bacteriophage A Gem-11 (Promega) library containing EcoRI fragments larger than 9 kilobases (kb) was prepared and screened for colonies hybridizing to a MMTV LTR probe (13) . BamHI-, Pvu II-, and Sst I-digested phage DNA from positive clones was analyzed by Southern blotting, using a MMTV env probe (13) . One clone was obtained containing a 12-kb 3' EcoRI junction fragment, consistent with Mtv-7 (14) . A probe specific for the flanking sequence was used in a Southern blot of DNA from recombinant inbred mice. Hybridization of this probe to a band differing in size between Mtv-7-positive and Mtv-7-negative strains confirmed the identity of the clone (5). The 3' EcoRI fragment was subcloned into the plasmid vector Bluescript KS (Stratagene) (clone 11-11, see Fig. 1 for orientation) .
Expression Vector Constructs. The BamHI-EcoRI fragment ofthe 3' Mtv-7junction fragment was subcloned into the pBABE hygromycin-resistance vector (15) to prepare pMo-BE. This fragment contains the complete Mtv-7 env gene and LTR as well as 8 kb of flanking host sequences. To prepare pMo-ES, II-11 was digested with HindIII and religated, removing most of the flanking sequence. The EcoRI-Sal I fragment from this construct was subcloned into the pBABE puromycin-resistance vector (15) . pMo-BS was made by subcloning the BamHI-Sca I fragment containing the entire Mtv-7 env gene and parts of the LTR into the BamHI-SnaBI sites of the pBABE hygromycin-resistance vector. Sca I cuts in the middle of the ORF; thus this vector allows expression of the env gene alone. For the pMo-BC construct, the Hpa II fragment containing the Mtv-7 env and U3 region of the LTR was subcloned into the Cla I site of Bluescript KS (Stratagene). A Bgl II-EcoRI fragment containing only the ORF was subcloned into the pBABE hygromycin-resistance vector. pMo-ES was digested with Bgl II and religated to make pMo-Bgl. This procedure removed the env gene; thus pMoBgl contains only the ORF. The ORF was cloned with PCR using the following set of primers (see Fig. 4A for primer binding sites): 5'-GGGAATTCATGCCGCGCCTGCAG-3' and 5'-GGGTCGACAGATCTCCGCAAGTAGACCTG-3'. The amplified fragment was digested with EcoRI-Sal I and subcloned into the pBABE puromycin-resistance vector to prepare pMo-ORF. The PCR amplified ORF fragment was subcloned into the EcoRI-Bgl II sites ofthe pSP72 polylinker (Promega subcloned into the Sal I-BamHI sites of pHPAPr-1-neo (16) to make pH,3A-ORF (see Figs. 1 and 3 ).
Southern Blot Analysis. Digested genomic DNA was Southern blotted to Zetabind (AMF-Cuno), as described (17), and hybridized with a 32P-labeled MMTV LTR probe (13) .
Sequencing. The plasmid II-11 and subclones thereof were used for DNA sequencing. Both strands were sequenced using Sequenase Version 2.0 (USB), with two plasmidspecific primers ("KS" and "SK") and six MMTV oligonucleotide primers, based on the MMTV (C3H) sequence and chosen for their conservation among other published MMTV sequences. MMTV plus strand primers were U3-3 (nucleotides 343-357), U3-1 (nucleotides 438-452), and U3-5 (nucleotides 647-661). Minus strand primers were U3-2 (nucleotides 1121-1106), U3-6 (nucleotides 828-814), and U34 (nucleotides 397-383) (see Fig. 4A for nucleotide sequences). Either double-stranded DNA or single-stranded DNA rescued with VCSM13 helper phage (Stratagene) was used as template.
Cell Lines and Medium. LBB.A, an Mls-i-expressing B-cell hybridoma derived from a fusion of BALB/c and RF/J parents, its Mls-1-negative variant LBB.11, and the V36 T-cell hybridoma RG17 were a kind gift of A. Glasebrook (18) . Cells were maintained in complete medium, consisting of RPMI 1640 medium (GIBCO) supplemented with 10%1o fetal calf serum, 10 mM Hepes (pH 7.2), 50 ,iM mercaptoethanol, 2 mM glutamine, 100 units of penicillin per ml, and 100 ,ug of streptomycin per ml (JRH).
Complement Lysis. Lyl7.1 is an allelic form of the Fc'yR that maps to the distal part of chromosome 1 near Mtv-7 (19) . LBB.A and LBB.11 cells were incubated on ice for 20 min with an anti-Lyi7.1-specific monoclonal antibody (gift of S. Kimura) or an anti-Ek monoclonal antibody (14.4.4s, ATCC), followed by complement treatment for 30 min at 37°C. Viability of the cells was assessed by trypan blue exclusion. Specific lysis was determined as 100 x (1 -cell count after monoclonal antibody plus complement/cell count after complement only).
Transfection. pBABE-derived plasmids were linearized with Not I, and the pHf3A-ORF plasmid was linearized using Nde I (both obtained from New England Biolabs). LBB.11 cells (5 x 106 per 0.5 ml of cold PBS) were (4) .
To further define the sequences encoding Mls-1, we tested various deletion constructs. First, removal of the 8-kb flanking sequence had no effect on activity, confirming the role of MMTV sequences (pMo-ES). Surprisingly, however, neither the env (pMo-BS) nor the LTR ORF alone (pMo-BC) conferred significant Mls-1 activity in conjunction with a Mo-MLV LTR (Fig. 3) , regardless of IL-4 preincubation. Since these results seemed to contrast findings of other groups (9-12), we prepared two additional constructs containing the Mtv-7 ORF-one by using other restriction sites for isolating this fragment (pMo-Bgl) and the other by cloning the ORF without additional sequences using the PCR. Since the same negative expression results were obtained with these constructs, we suspected that the apparent discrepancy in expression might reside with the specific promoter. Thus, we tested the ORF in conjunction with the human ,B-actin promoter, known to direct efficient expression in a wide variety of cells (16) , and found high levels of activity (pHfA-ORF) (Fig. 3) . The dependence on IL-4 seemed to be less pronounced in these transfectants (results not shown).
These experiments demonstrate that the ORF alone can confer Mls-1 activity, in agreement with findings that ORFs of other exogenous and endogenous MMTVs encode superantigen activity (9) (10) (11) (12) Proc. Natl. Acad. Sci. USA 89 (1992) 5435
Conceivably, such an effect operating on the Mo-MLV LTR might be responsible for the phenomena we have observed here. It is possible that the ORF protein, translated from the spliced 3' LTR message, down-regulates the MMTV promoter, thus acting as a self-regulator of expression. This would explain why it has been notoriously difficult to detect expression of this protein, even in mammary tumor cells (24, 25) . Alternatively, expression of the ORF at high levels might be toxic to cells, leading to unpredictable selection of variant clones with low expression. Nucleotide Sequence and Predicted Amino Acid Sequence of MOv-7 ORF. To ascertain whether and how distinct sequences in the ORF might correlate with distinct superantigen activities (i.e., Vf3 recognition), we have determined the nucleotide sequence ofthe Mtv-7 LTR ORF (Fig. 4A ) and compared its predicted amino acid sequence to that of other MMTV ORFs (13, (26) (27) (28) (29) (Fig. 4B) . The overall structure is highly conserved among endogenous and exogenous viruses, but the Mtv-7 sequence diverges significantly in two regions from that of the other known ORF sequences: region I (from amino acid 174 to amino acid 197) differs at dispersed amino acids, most of which constitute nonconservative changes. Region II (from amino acid 295 to amino acid 322) is located at the C terminus, where the last 14 amino acids are unique for Mtv-7. It is, therefore, plausible that one or both of these regions contribute specificity to the binding site of the TCR Vp chain.
Additionally, these regions could influence the superantigen/ major histocompatibility complex class II interaction, presumably an important factor determining the magnitude of the elicited T-cell response because ofthe observed hierarchy in the capacity of the various class II molecules to support superantigen activity. Specific recombinants to test the role of these regions must be made.
Conclusions. The possibility that the VP specificity resides in the C terminus would seem to require that this region be exposed on the cell surface. Such a structure is consistent with the presence of a stretch of mostly hydrophobic amino acids at amino acids 45-63, which might indicate a type II transmembrane protein. Furthermore, the five potential N-linked glycosylation sites on the C-terminal side of the putative transmembrane segment show that this portion must lie outside the membrane, since translation and expression studies have shown that the protein encoded by the ORF is modified by about this amount of N-linked glycosylation (24, 25) . Of interest are two arginine-rich segments (RXRR) that resemble cleavage sites in retrovirally encoded env proteins (22) . It is possible, therefore, that the MMTV ORF-encoded protein consists of a transmembrane and an extracellular peptide. Experiments are necessary to confirm these predictions by analyzing the protein encoded by the ORF. Antisera have been raised against recombinant Mtv-7 ORF protein and peptides, which should provide the tools for these studies (D. Mottershead, N. Mohan, M. Subramanyam, and B.T.H., unpublished data).
Because the ORF of various MMTVs has been shown to encode superantigen activities (refs. 9-12, and present results), we propose that this gene be renamed "sag." This proposal is similar to the suggestion of Choi et al. (9) , but is in agreement with conventions for naming retroviral genes (30, 31) .
